1 证券代码：002440 证券简称：闰土股份 浙江闰土股份有限公司投资者关系活动记录表 编号：RTIR-2022-001 | --- | --- | --- | |-------------------|------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | □特定对象调研 □分析师会议 | | | | □媒体采访 √业绩说明会 | | | 投资者关系活动 | □新闻发布会 □路演活动 | | | 类别 | □现场参观 | | | | □其他 | | | 参与单位名称及 | 通过全景网网络平台参与公司 ...

浙江闰土股份有限公司 2022 年第三季度报告 证券代码：002440 证券简称：闰土股份 公告编号：2022-028 浙江闰土股份有限公司 2022 年第三季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 重要内容提示： 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准确、完整，不存在虚假记载、误导性陈述或重 大遗漏，并承担个别和连带的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声明：保证季度报告中财务信息的真实、准确、 完整。 3.第三季度报告是否经过审计 □是 否 1 浙江闰土股份有限公司 2022 年第三季度报告 一、主要财务数据 （一） 主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | --- | |-----------------------------------------------------|-------------------|-------------------------|--------------- ...

Financial Performance - The company reported a revenue of 1.2 billion RMB for the first half of 2022, representing a year-on-year increase of 15%[23]. - The net profit attributable to shareholders for the same period was 200 million RMB, up 10% compared to the previous year[23]. - The company's operating revenue for the reporting period reached ¥3,419,968,468.85, representing a year-on-year increase of 24.12%[30]. - The net profit attributable to shareholders was ¥499,651,175.24, up 24.69% compared to the same period last year[30]. - The net cash flow from operating activities increased significantly by 113.94%, amounting to ¥1,218,596,558.73[30]. - The total assets at the end of the reporting period were ¥12,722,178,984.54, reflecting an 11.29% increase from the previous year[30]. - The operating cost increased by 30.59% to ¥2,570,459,814.26 from ¥1,968,303,412.78, primarily due to the growth in operating revenue[47]. - The company achieved a gross profit of ¥66,983,320, representing a year-on-year growth of 29.44%[39]. - The company reported a significant increase in other income, which rose by 77.54% to ¥146,734,066.14, mainly due to increased government subsidies[49]. - The company reported a net profit for the first half of 2022 of ¥495,630,793.37, representing a 27.2% increase from ¥389,574,663.31 in the previous year[200]. Investment and Growth Strategies - The company plans to increase its investment in environmental protection by 20% in response to the new environmental laws[11]. - The company aims to expand its market share by 5% in the next year through strategic adjustments in procurement and sales[12]. - The company is focusing on the development of new dye products, with an expected launch of three new products by the end of 2022[23]. - The company has been focusing on "backward integration" strategies, enhancing its supply chain and production processes[39]. - The company reported a significant increase in R&D investment to improve production processes and promote new product development[39]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[200]. Environmental Compliance and Initiatives - The company has achieved compliance with emission standards for various pollutants, including SO2 and NOX, across its production facilities[104]. - The company’s COD emissions from Dibang Chemical were 56.301 tons, with a permitted limit of 149.22 tons per year, indicating compliance with standards[94]. - The company has established five sets of 200t/h MVR devices and two sets of 60t/h multi-effect concentration devices for resource recovery of low-concentration acidic wastewater and saline wastewater, with a daily treatment capacity of 20,000 tons[103]. - The company has implemented a comprehensive hazardous waste management system, ensuring proper storage and disposal in compliance with relevant regulations[105]. - The company has established a wastewater treatment station with a daily capacity of 20,000 tons, which processes both production and domestic wastewater[103]. - The company has implemented an environmental emergency response plan and has filed it with local environmental protection authorities[109]. Financial Management and Investments - The company has ongoing equity investments totaling ¥290,000,000.00, with significant stakes in various companies, including a 20% stake in Jiangxi Huaju Energy Technology Co., Ltd.[67]. - The total approved guarantee amount for subsidiaries is CNY 77,000 million, with actual guarantees incurred during the reporting period amounting to CNY 13,300 million[144]. - The total amount of entrusted financial management is CNY 79,950 million, with no overdue amounts or impairment provisions recorded[147]. - The company has invested CNY 62,000 million in bank financial products, CNY 3,000 million in broker financial products, and CNY 14,950 million in trust financial products[147]. - The company maintains a diversified investment strategy through various financial products, enhancing its financial stability and growth potential[147]. Shareholder Information and Corporate Governance - The company reported a participation rate of 46.35% in the 2021 annual shareholders' meeting held on May 20, 2022[87]. - The company does not plan to distribute cash dividends or issue bonus shares for the half-year period[89]. - The total number of common shareholders at the end of the reporting period was 40,941[167]. - The largest shareholder, Zhang Aijuan, holds 16.73% of shares, totaling 192,454,893 shares[169]. - The company repurchased a total of 26,500,095 shares, accounting for 2.3034% of the total share capital[169]. - The company’s financial report for the half-year period was not audited[183]. Risk Management - The company has identified risks related to raw material price fluctuations, which could impact production costs and overall performance[12]. - The company is closely monitoring macroeconomic trends to adjust its business strategies accordingly[8]. - The company faces market risks due to macroeconomic conditions and commodity price volatility, which can impact production costs and performance[84]. - The company has a dedicated team responsible for risk assessment and management of derivatives trading, including representatives from finance, auditing, and legal departments[71].

Financial Performance - The company aims to achieve a total operating revenue of no less than 6 billion RMB and a total profit of no less than 1 billion RMB in 2022[5]. - The profit distribution plan proposes a cash dividend of 3.5 RMB (including tax) for every 10 shares, totaling approximately 393.4 million RMB[11]. - The company's operating revenue for 2021 was ¥5,572,265,054.85, representing a 6.58% increase compared to ¥5,228,130,173.91 in 2020[36]. - The net profit attributable to shareholders for 2021 was ¥835,615,920.37, a 6.02% increase from ¥788,176,752.31 in 2020[36]. - The net profit after deducting non-recurring gains and losses was ¥607,377,790.11, up 9.19% from ¥556,262,543.48 in 2020[36]. - The company achieved a total revenue of 5.57 billion yuan in 2021, representing a year-on-year growth of 6.58%[82]. - The company's net profit attributable to shareholders was 836 million yuan, an increase of 6.02% compared to the previous year[79]. - The total revenue for the company reached 255.66 million, with a significant increase of 5.5% compared to the previous period[166]. - The company reported a net profit of 250.16 million, reflecting a growth of 4.5% year-over-year[166]. Research and Development - The company will continue to invest in research and development of new products and technologies to support market expansion and competitiveness[5]. - The company invested approximately 249.81 million yuan in R&D during the reporting period, resulting in 25 authorized invention patents and 5 utility model patents[77]. - The company has applied for 222 invention patents and 18 utility model patents related to its core technologies in dye production, indicating a strong R&D capability[66]. - The company is focusing on technological innovation and has been recognized as a key enterprise research institute by the Zhejiang Provincial Science and Technology Department[81]. - The company plans to enhance R&D investment and improve production processes to strengthen its competitive edge in the dye industry[138]. - The company has allocated 1.5 million for research and development to enhance product offerings and technology[167]. Market and Industry Dynamics - The company will closely monitor national macroeconomic trends and adjust its development strategies accordingly to mitigate risks from policy changes in the textile dyeing industry[6]. - The company plans to implement flexible strategies to manage market risks, including price fluctuations and increased competition in the dyeing industry[10]. - The company maintains a leading market share in the domestic dye market, ranking among the top two in terms of sales[58]. - The dye industry is highly competitive, with increased domestic supply leading to intensified market competition, potentially resulting in lower sales prices or reduced capacity utilization[148]. - The company is responding to stricter environmental regulations by upgrading production equipment and increasing investment in environmental technology[54]. Environmental and Safety Initiatives - The company emphasizes safety production and will increase investments in safety management, adopting advanced safety management methods[7]. - Environmental protection investments will continue to increase, impacting upstream raw material suppliers and the company's operational strategies[10]. - The company is committed to resource recycling and emission reduction, which has improved operational efficiency and reduced environmental pressure[57]. - The company aims to achieve a green and low-carbon transformation in line with national policies during the "14th Five-Year Plan" period[50]. - The company is committed to increasing environmental protection investments to comply with new regulations and ensure sustainable operations[147]. Operational Efficiency - The company will enhance its procurement strategies to ensure a stable supply of raw materials in response to market trends[10]. - The company has implemented a "backward integration" strategy to extend its industrial chain, reduce production costs, and mitigate the impact of intermediate price fluctuations on operations[57]. - The company has established a complete industrial chain from thermal power, steam, chlorine, and caustic soda to intermediates and dyes, enhancing its market risk resilience[76]. - The company employs a production management model that combines make-to-order for non-standard products and stockpiling for conventional products[62]. - The company has a self-built 30MW cogeneration project to reduce overall electricity costs, with electricity costs accounting for 62% of caustic soda production costs[72]. Financial Management - The company has no fundraising activities during the reporting period, indicating a stable financial position[131]. - The company has not engaged in any major asset or equity sales during the reporting period, maintaining its asset base[132][134]. - The company reported a significant decrease in net cash increase of -¥951,796,624.99, compared to an increase of ¥1,047,082,104.84 in the previous year, reflecting a 190.90% decline[105]. - The company has established risk management measures for derivative trading, including market risk and credit risk assessments[127]. Human Resources - The total number of employees at the end of the reporting period was 5,141, with 491 in the parent company and 4,650 in major subsidiaries[196]. - The professional composition of employees includes 3,659 production personnel, 93 sales personnel, 722 technical personnel, 76 financial personnel, and 591 administrative personnel[196]. - The company has established a competitive compensation and benefits system, including medical assistance funds and special subsidies, to create a favorable working environment for employees[200]. Corporate Governance - The total remuneration for directors, supervisors, and senior management in 2020 was 8.4133 million CNY, while for 2021, it was confirmed to be 7.42 million CNY[181]. - The independent director allowance was set at 120,000 CNY per person per year, as approved by the board[181]. - The company held four board meetings in 2021, with significant resolutions including the approval of the 2021 Q1 report and the 2021 semi-annual report[185]. - The total remuneration for the board members in 2021 was 821.50 thousand CNY, with individual payments varying among members[183].

浙江闰土股份有限公司 2022 年第一季度报告全文 1 证券代码：002440 证券简称：闰土股份 公告编号：2022-017 浙江闰土股份有限公司 2022 年第一季度报告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没 有虚假记载、误导性陈述或重大遗漏。 重要内容提示: 1.董事会、监事会及董事、监事、高级管理人员保证季度报告的真实、准 确、完整，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带 的法律责任。 2.公司负责人、主管会计工作负责人及会计机构负责人(会计主管人员)声 明：保证季度报告中财务信息的真实、准确、完整。 3.第一季度报告是否经过审计 □ 是 √ 否 一、主要财务数据 (一)主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 | --- | --- | --- | --- | |----------------------------------------------------|-------------------|-------------------|---------------------------| | | 本报告期 | 上年同期 | ...

[Key Financial Data](index=1&type=section&id=I.%20Key%20Financial%20Data) The company achieved double-digit revenue and net profit growth in Q1-Q3 2021, with Q3 net profit significantly boosted by non-recurring gains, while operating cash flow declined due to reduced subsidies and increased procurement [Key Accounting Data and Financial Indicators](index=1&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) In Q1-Q3 2021, the company's operating revenue reached CNY 4.25 billion with 16.33% growth, and net profit attributable to shareholders was CNY 669 million with 20.10% growth Key Financial Indicators for Q1-Q3 and Q3 2021 | Indicator | Year-to-Date (YTD) | YTD YoY Change | Current Period (Q3) | Current Period YoY Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue (CNY) | 4,251,112,041.11 | 16.33% | 1,495,737,939.70 | 7.69% | | Net Profit Attributable to Parent Company Shareholders (CNY) | 668,701,306.65 | 20.10% | 267,998,253.29 | 47.71% | | Net Profit Attributable to Parent Company Shareholders Excluding Non-recurring Gains and Losses (CNY) | 466,372,546.81 | 26.41% | 159,296,198.83 | -11.03% | | Net Cash Flow from Operating Activities (CNY) | 777,555,218.29 | -49.25% | - | - | | Basic Earnings Per Share (CNY/share) | 0.59 | 22.92% | 0.240 | 50.00% | [Non-recurring Gains and Losses Items and Amounts](index=1&type=section&id=Non-recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) In Q1-Q3 2021, non-recurring gains and losses totaled approximately CNY 202 million, significantly impacting net profit, primarily from fair value changes in the investment in Guobang Pharmaceutical and government subsidies 2021 Q1-Q3 Major Non-recurring Gains and Losses Items | Item | Year-to-Date Amount (CNY) | Explanation | | :--- | :--- | :--- | | Gains and Losses from Changes in Fair Value of Trading Financial Assets and Liabilities | 154,943,917.13 | Primarily due to fair value changes in the investment in Guobang Pharmaceutical in the current period | | Government Subsidies Included in Current Period Profit/Loss | 86,455,670.98 | - | | **Total** | **202,328,759.84** | **--** | [Analysis of Key Financial Indicator Changes](index=2&type=section&id=Analysis%20of%20Key%20Financial%20Indicator%20Changes) Several financial indicators showed significant year-on-year changes, including substantial increases in prepayments and other non-current assets, a shift from short-term to long-term debt, and a decrease in operating cash flow due to reduced government subsidies and increased procurement - Balance sheet items showed significant changes, primarily in: - **Prepayments**: Increased by **103.99%** year-on-year due to increased prepayments for raw materials[7](index=7&type=chunk) - **Other Non-current Assets**: Increased by **261.51%** year-on-year due to increased prepayments for equipment[7](index=7&type=chunk) - **Short-term Borrowings**: Decreased by **90.82%** year-on-year due to repayment of borrowings[7](index=7&type=chunk) - **Long-term Borrowings**: Increased by **150.00%** year-on-year due to increased long-term bank borrowings[7](index=7&type=chunk) - **Treasury Stock**: Increased by **433.24%** year-on-year due to company share repurchases[7](index=7&type=chunk) - Income statement item changes were mainly due to: - **Selling Expenses**: Decreased by **51.70%** year-on-year because transportation costs were reclassified to operating costs under new revenue standards[10](index=10&type=chunk) - **R&D Expenses**: Increased by **51.14%** year-on-year as current period investment returned to normal levels after a lower base in the prior year due to the pandemic[10](index=10&type=chunk) - **Other Income** and **Non-operating Income**: Decreased by **54.34%** and **85.31%** year-on-year respectively, primarily due to reduced government subsidies received[10](index=10&type=chunk) - Net cash flow from operating activities decreased by **49.25%** year-on-year, mainly due to reduced government subsidies received, increased cash payments for raw material purchases (**+65.95%**), and increased tax payments (**+128.21%**)[10](index=10&type=chunk) [Shareholder Information](index=3&type=section&id=II.%20Shareholder%20Information) As of the reporting period end, the company had 38,244 shareholders, with a concentrated ownership structure where the controlling shareholder's family members collectively hold over 38% of shares, and the company completed a share repurchase plan representing 2.3034% of total share capital Top Three Shareholders' Holdings | Shareholder Name | Shareholder Nature | Shareholding Percentage | | :--- | :--- | :--- | | Zhang Aijuan | Domestic Natural Person | 16.73% | | Ruan Jingbo | Domestic Natural Person | 15.76% | | Ruan Jingxi | Overseas Legal Person | 5.58% | - Controlling shareholders Ruan Jingbo, Zhang Aijuan (Ruan Jingbo's mother), and Ruan Jingxi (Ruan Jingbo's sister) are parties acting in concert, indicating a concentrated equity structure[14](index=14&type=chunk) - As of July 16, 2021, the company completed its share repurchase plan, repurchasing a total of **26,500,095 shares** through centralized bidding, accounting for **2.3034%** of the company's total share capital[14](index=14&type=chunk) [Other Significant Matters](index=4&type=section&id=III.%20Other%20Significant%20Matters) During the reporting period, the company completed its share repurchase plan, expending approximately CNY 255 million, and its investment in Guobang Pharmaceutical Group Co., Ltd. through an M&A fund yielded significant book value growth and fair value change gains following its successful listing - The company's share repurchase plan was completed, with a cumulative repurchase of **26,500,095 shares**, representing **2.3034%** of total share capital, at a total cost of **CNY 255 million** (excluding transaction fees)[17](index=17&type=chunk) - Guobang Pharmaceutical, in which the company holds a stake through an M&A fund, was listed on the Shanghai Stock Exchange on August 2, 2021; as of the reporting period end, the company held **6.25 million shares**, representing **1.12%** of its total share capital, with a book value of **CNY 174 million**[17](index=17&type=chunk) [Quarterly Financial Statements](index=5&type=section&id=IV.%20Quarterly%20Financial%20Statements) As of September 30, 2021, the company's total assets were CNY 11.601 billion, with a healthy asset-liability ratio of 18.73%; Q1-Q3 2021 operating revenue was CNY 4.251 billion, net profit attributable to parent company shareholders was CNY 669 million, and net cash flow from operating activities was CNY 778 million, maintaining positive inflow despite a year-on-year decrease [Consolidated Balance Sheet](index=5&type=section&id=Consolidated%20Balance%20Sheet) As of September 30, 2021, the company's total assets were CNY 11.601 billion, a 2.17% increase from the beginning of the year, with total liabilities of CNY 2.173 billion resulting in a low asset-liability ratio of 18.73%, and total equity attributable to parent company shareholders was CNY 9.259 billion, up 1.16% from year-start Balance Sheet Major Items (Unit: CNY) | Item | September 30, 2021 | December 31, 2020 | | :--- | :--- | :--- | | Total Assets | 11,600,884,782.17 | 11,354,172,670.91 | | Total Liabilities | 2,173,303,786.19 | 2,014,129,580.06 | | Total Equity Attributable to Parent Company Shareholders | 9,258,740,754.19 | 9,152,853,542.48 | [Consolidated Income Statement](index=7&type=section&id=Consolidated%20Income%20Statement) In Q1-Q3 2021, the company's total operating revenue reached CNY 4.251 billion, a 16.33% year-on-year increase, with total operating costs of CNY 3.696 billion, up 14.29% year-on-year, and net profit attributable to parent company shareholders was CNY 669 million, growing 20.10% year-on-year, significantly boosted by CNY 154 million in fair value change gains 2021 Q1-Q3 Income Statement Major Items (Unit: CNY) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | I. Total Operating Revenue | 4,251,112,041.11 | 3,654,209,230.30 | | II. Total Operating Costs | 3,696,152,018.40 | 3,234,117,772.89 | | Gains from Changes in Fair Value | 153,548,296.75 | 204,084.95 | | IV. Total Profit | 857,208,393.75 | 684,623,577.31 | | Net Profit Attributable to Parent Company Shareholders | 668,701,306.65 | 556,787,261.14 | | Basic Earnings Per Share | 0.59 | 0.48 | [Consolidated Cash Flow Statement](index=9&type=section&id=Consolidated%20Cash%20Flow%20Statement) In Q1-Q3 2021, net cash flow from operating activities was CNY 778 million, a 49.25% year-on-year decrease primarily due to reduced government subsidies and increased procurement payments, while net cash outflow from investing activities was CNY 579 million and from financing activities was CNY 648 million, resulting in a period-end cash and cash equivalents balance of CNY 1.581 billion, a decrease of CNY 452 million from the beginning of the year 2021 Q1-Q3 Cash Flow Statement Major Items (Unit: CNY) | Item | Current Period Amount | Prior Period Amount | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 777,555,218.29 | 1,532,192,284.44 | | Net Cash Flow from Investing Activities | -579,446,251.83 | -6,592,719.72 | | Net Cash Flow from Financing Activities | -647,978,425.45 | -346,916,436.01 | | Net Increase in Cash and Cash Equivalents | -452,193,708.36 | 1,176,896,869.53 | | Cash and Cash Equivalents at Period End | 1,580,635,526.51 | 2,162,643,999.56 |

Financial Performance - The company's operating revenue for the first half of 2021 was CNY 2,755,374,101.41, representing a 21.64% increase compared to CNY 2,265,268,848.03 in the same period last year[32]. - The net profit attributable to shareholders of the listed company was CNY 400,703,053.36, a 6.75% increase from CNY 375,356,836.46 in the previous year[32]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 307,076,347.98, showing a significant increase of 61.70% compared to CNY 189,904,049.31 last year[32]. - The operating profit reached 517.49 million yuan, reflecting a year-on-year growth of 14.61%[43]. - The basic earnings per share increased by 6.06% to CNY 0.35, compared to CNY 0.33 in the same period last year[32]. - The diluted earnings per share also increased by 6.06% to CNY 0.35, consistent with the basic earnings per share[32]. - The weighted average return on net assets was 4.43%, slightly up from 4.28% in the previous year[32]. Cash Flow and Assets - The net cash flow from operating activities decreased by 53.15%, amounting to CNY 569,606,122.73, down from CNY 1,215,756,907.13 in the previous year[32]. - The total assets at the end of the reporting period were CNY 11,117,235,025.65, a decrease of 2.09% from CNY 11,354,172,670.91 at the end of the previous year[32]. - The net assets attributable to shareholders of the listed company were CNY 9,020,746,729.14, down 1.44% from CNY 9,152,853,542.48 at the end of the previous year[32]. - The company's cash and cash equivalents decreased by 140.61% to -¥407,847,245.98, reflecting a significant reduction in government subsidies received[51]. - The total current assets as of June 30, 2021, amounted to CNY 5,627,751,853.22, a decrease from CNY 6,232,264,668.44 at the end of 2020, reflecting a decline of approximately 9.7%[192]. - Non-current assets totaled CNY 5,489,483,172.43, up from CNY 5,121,908,002.47, reflecting an increase of approximately 7.2%[194]. Investments and R&D - R&D investment for the reporting period amounted to 111.42 million yuan, with 4 invention patents and 2 utility model patents applied for[49]. - Research and development investment increased significantly by 98.17% to ¥111,421,283.59, recovering from a decrease in the previous year due to COVID-19 impacts[51]. - The company has received a total of 258 authorized invention patents and 21 utility model patents as of the end of the reporting period[49]. Market Position and Strategy - The company maintains a strong market position, ranking among the top two in the domestic dye market share[43]. - The company has implemented a "backward integration" strategy, enhancing its supply chain and reducing production costs[48]. - The company plans to closely monitor macroeconomic trends and adjust its development strategies accordingly to mitigate risks associated with industry policies and market fluctuations[7]. Environmental Compliance - The company is classified as a key pollutant discharge unit by environmental protection authorities[93]. - The company has implemented measures to ensure that all emissions are within the regulatory limits, demonstrating a commitment to environmental compliance[100]. - The company has established a wastewater treatment facility with a capacity of 5,000 tons/day, utilizing advanced treatment processes to ensure compliance before discharge into the park's wastewater treatment plant[103]. - The company achieved a total COD discharge of 39.364 tons and ammonia nitrogen discharge of 0.641 tons, both within the permitted limits[93]. Shareholder and Governance - The company has established a robust corporate governance structure to protect the rights of shareholders and creditors, ensuring timely and accurate information disclosure[110]. - The company has not distributed cash dividends or issued bonus shares for the reporting period[88]. - The company repurchased a total of 26,500,095 shares from 2020 to 2021, with a total expenditure of approximately 255 million yuan[110]. - The company’s major shareholders include Zhang Aijuan with 192,454,893 shares (16.73%) and Ruan Jingbo with 181,331,054 shares (15.76%) as of the report date[168]. Legal and Regulatory Matters - The semi-annual financial report was not audited[118]. - There were no major litigation or arbitration matters during the reporting period[120]. - The company faced administrative penalties totaling RMB 49,000 and RMB 39,000 for safety violations by Jiacheng Chemical[124]. - The company has actively taken corrective measures to address the issues identified by the regulatory authority[124].

证券代码：002440 证券简称：闰土股份 公告编号：2021-027 浙江闰土股份有限公司 关于举办 2020 年度网上业绩说明会暨参加浙江辖区 上市公司投资者网上集体接待日主题活动的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 为进一步加强与投资者的沟通交流，浙江闰土股份有限公司（以下简称"公 司"）定于 2021 年 5 月 13 日（星期四）下午 15:00-17:00 在全景网举办 2020 年 度业绩说明会暨参加由浙江证监局指导、浙江上市公司协会与深圳市全景网络有 限公司共同举办的浙江辖区上市公司投资者网上集体接待日主题活动，现将有关 事项公告如下： 本次活动将通过深圳市全景网络有限公司提供的网上平台举行，投资者可登 录"全景•路演天下"（http://rs.p5w.net）参与本次活动。 出席本次活动的人员有：总经理徐万福先生、财务总监周成余先生、董事会 秘书刘波平先生，具体以当天实际参会人员为准。 欢迎广大投资者积极参与。 特此公告。 | --- | --- | --- | --- | |-------|-------|-------| ...

Financial Performance - The company's operating revenue for Q1 2021 was ¥1,416,761,800.01, representing a 23.92% increase compared to ¥1,143,295,829.45 in the same period last year[10] - Net profit attributable to shareholders was ¥176,455,249.39, a decrease of 23.40% from ¥230,368,577.42 year-on-year[10] - The net profit after deducting non-recurring gains and losses was ¥131,611,719.49, showing a significant increase of 133.44% compared to ¥56,378,882.31 in the previous year[10] - Basic earnings per share decreased by 25.00% to ¥0.15 from ¥0.20 year-on-year[10] - The company reported a net profit of approximately ¥6.39 billion in retained earnings, an increase from ¥6.21 billion[59] - Total operating revenue for the current period reached ¥1,416,761,800.01, an increase of 23.9% compared to ¥1,143,295,829.45 in the previous period[68] - Net profit for the current period was ¥171,491,445.85, a decrease of 23.2% from ¥223,008,268.00 in the previous period[74] - The total comprehensive income attributable to the parent company is CNY 177,591,773.64, compared to CNY 230,938,419.07 in the previous period, reflecting a decrease of 23.1%[77] Cash Flow and Liquidity - The net cash flow from operating activities was ¥57,752,462.09, down 88.90% from ¥520,197,091.61 in the same period last year[10] - The company’s cash outflow from operating activities increased by 94.22% to 985,494,855.09 from 507,422,001.00 primarily due to higher cash payments for raw materials and taxes[26] - Cash and cash equivalents decreased by 30.46% to 1,435,741,579.44 from 2,064,637,158.63 due to repayment of short-term bank loans[23] - The company reported a net decrease in cash and cash equivalents of -586,642,305.09, contrasting with an increase of 310,351,180.14 in the previous period[96] - The ending balance of cash and cash equivalents was 1,016,475,953.39, an increase from 542,112,971.97 in the previous period[96] Assets and Liabilities - Total assets at the end of the reporting period were ¥11,018,881,069.67, a decrease of 2.95% from ¥11,354,172,670.91 at the end of the previous year[10] - Total liabilities decreased significantly with short-term borrowings dropping to 0.00 from 370,302,222.22, reflecting repayment of bank loans[23] - Current liabilities decreased to approximately ¥1.31 billion, down by 24.87% from ¥1.75 billion[56] - Total liabilities decreased to ¥1,183,151,428.74 from ¥1,275,747,352.78, a decline of about 7.3%[66] - The total equity attributable to shareholders increased to approximately ¥9.26 billion, up by 1.15% from ¥9.15 billion[59] Research and Development - Research and development expenses rose by 68.39% to 40,284,044.94 from 23,922,990.38 as R&D investments returned to normal levels after a decrease due to COVID-19 impacts last year[23] - Research and development expenses rose to ¥40,284,044.94, compared to ¥23,922,990.38 in the previous period, marking an increase of 68.3%[71] - The company reported investment income of ¥22,536,657.28, up from ¥13,323,950.61, representing a growth of 69.0%[71] Shareholder Activities - The company repurchased a total of 12,750,000 shares, accounting for 1.1082% of the total share capital, with a total expenditure of approximately RMB 122.32 million[31] - The maximum transaction price during the share repurchase was RMB 9.95 per share, while the minimum was RMB 9.15 per share[31] - The company plans to use its own funds to repurchase shares for employee stock ownership plans, with a total repurchase fund not less than RMB 200 million and not exceeding RMB 400 million[31] Government and Regulatory - The company reported government subsidies of ¥53,099,847.01 during the reporting period[10] - The company reported a 192.13% increase in taxes and surcharges to 15,328,104.11 from 5,246,995.19 due to higher payable additional taxes compared to the same period last year[23] - There were no overdue amounts or uncollected funds from entrusted financial management during the reporting period[40] - There were no violations of external guarantees during the reporting period[43] - The company did not have any non-operating fund occupation by controlling shareholders or related parties during the reporting period[44] Investment Activities - The company has invested 3,800,000 RMB in a healthcare-focused venture capital fund through its wholly-owned subsidiary, indicating a strategic move into the healthcare sector[30] - The company’s major financial investments include RMB 68 million in bank wealth management products and RMB 3 million in securities firm wealth management products, totaling RMB 71 million[40]

Financial Performance - The company's operating revenue for 2020 was ¥5,228,130,173.91, a decrease of 19.73% compared to ¥6,513,168,920.40 in 2019[32]. - The net profit attributable to shareholders for 2020 was ¥788,176,752.31, down 42.47% from ¥1,369,965,968.02 in 2019[32]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥556,262,543.48, a decline of 48.26% from ¥1,075,108,188.82 in 2019[32]. - The net cash flow from operating activities was ¥1,547,847,445.81, a decrease of 15.86% compared to ¥1,839,697,241.26 in 2019[32]. - The total assets at the end of 2020 were ¥11,354,172,670.91, an increase of 4.06% from ¥10,910,713,769.79 at the end of 2019[32]. - The net assets attributable to shareholders at the end of 2020 were ¥9,152,853,542.48, up 4.30% from ¥8,775,344,168.56 at the end of 2019[32]. - The basic earnings per share for 2020 was ¥0.69, down 42.02% from ¥1.19 in 2019[32]. - The weighted average return on equity for 2020 was 8.81%, a decrease of 7.65% from 16.46% in 2019[32]. - The company reported a total of ¥261,577,742.68 in government subsidies related to its business for 2020[38]. - The company's operating profit was ¥920,483,000.65, down 41.32% year-on-year, and net profit attributable to shareholders was ¥788,176,752.31, a decrease of 42.47%[66]. - The total sales of dyes for the year reached 163,000 tons, representing a year-on-year decline of 2.98%[67]. Investment and R&D - The company invested 196.63 million yuan in R&D during the reporting period, applying for 28 invention patents and obtaining 27 authorized invention patents[61]. - The company’s R&D projects included 70 initiatives, with 32 completed, focusing on environmentally friendly dyes and production processes[102]. - The company's R&D investment in 2020 was ¥196,627,205.23, which is a decrease of 14.70% compared to ¥230,508,318.21 in 2019[105]. - The number of R&D personnel increased by 17.19% from 768 in 2019 to 900 in 2020, with R&D personnel accounting for 17.56% of the total workforce[105]. Safety and Environmental Management - The company emphasizes the importance of safety in production and will continue to invest in safety management practices, including the adoption of advanced safety management methods from Australia[10]. - The company will focus on maintaining a good safety environment and enhancing grassroots safety supervision to ensure safe production practices[10]. - The company will increase its investment in environmental protection in response to the new Environmental Protection Law, which may affect upstream raw material suppliers[11]. - The company aims to control costs and adjust procurement and sales strategies in response to market fluctuations caused by stringent environmental regulations[12]. - The company emphasizes environmental protection, aiming for a reduction in waste and a commitment to green and safe production practices[138]. - Safety and environmental management are prioritized, with ongoing investments in safety production and adherence to advanced safety management methods[146]. Market and Strategic Positioning - The company has a strong market position, with approximately 70% of the world's dye production occurring in China, where Zhejiang Runtu is among the top dye manufacturers[137]. - The company will enhance its market sales strategy to balance production and sales effectively, ensuring timely collection of accounts receivable[141]. - The company will closely monitor macroeconomic trends and adjust its development strategies in response to changes in national industrial policies that impact the textile dyeing industry[7]. - The company acknowledges the ongoing risks posed by the COVID-19 pandemic and will actively assess its impact on the industry chain to mitigate adverse effects on operations[13]. - The company is aware of risks related to macroeconomic changes and will adjust its strategies accordingly to mitigate these risks[145]. Profit Distribution and Dividends - The company plans to distribute a cash dividend of 3.5 RMB per 10 shares (including tax) based on a total share base of 1,128,131,505 shares after accounting for share repurchases[16]. - The company distributed cash dividends of RMB 394,846,026.75 for the fiscal year 2020, which is 50.10% of the net profit attributable to ordinary shareholders[160]. - The cash dividend per 10 shares for 2020 was set at RMB 3.5, based on a total share capital of 1,150,500,000 shares, excluding 22,368,495 shares held in the repurchase account[161]. - The total distributable profit for the company as of December 31, 2020, was RMB 3,394,530,160.04[161]. - The company has maintained a clear and transparent cash dividend policy, ensuring that minority shareholders have the opportunity to express their opinions[161]. Operational Efficiency - The company focused on enhancing management efficiency and cost reduction through various operational reforms[70]. - The company has implemented significant technological upgrades, improving production efficiency and reducing costs through projects like the continuous production of nitrosylsulfuric acid[68]. - The company has a self-built 30MW cogeneration project, which helps reduce overall electricity costs[83]. - The company maintained a stable production process with no significant changes in major energy types during the reporting period[73]. Compliance and Risk Management - The company is actively renewing necessary permits and licenses for production operations, ensuring compliance with regulatory requirements[80]. - The company has established a derivative trading management system to mitigate risks associated with financial derivatives[126]. - The company’s risk management measures include careful selection of trading partners and adherence to established trading principles[126]. - The company did not experience any major litigation or arbitration matters during the reporting period[173]. - The company maintained a good credit status with no significant debts due that were unpaid during the reporting period[178].